Literature DB >> 24209967

Failure-to-thrive syndrome associated with tumor formation by Madin-Darby canine kidney cells in newborn nude mice.

Lauren R Brinster1, Romelda L Omeir, Gideon S Foseh, Juliete N Macauley, Philip J Snoy, Joel J Beren, Belete Teferedegne, Keith Peden, Andrew M Lewis.   

Abstract

Tumors that formed in newborn nude mice that were inoculated with 10(7) Madin-Darby canine kidney (MDCK) cells were associated with a failure-to-thrive (FTT) syndrome consisting of growth retardation, lethargy, weakness, and dehydration. Scoliosis developed in 41% of affected pups. Pups were symptomatic by week 2; severely affected pups became moribund and required euthanasia within 3 to 4 wk. Mice with FTT were classified into categories of mild, moderate, and severe disease by comparing their weight with that of age-matched normal nude mice. The MDCK-induced tumors were adenocarcinomas that invaded adjacent muscle, connective tissue, and bone; 6 of the 26 pups examined had lung metastases. The induction of FTT did not correlate with cell-line aggressiveness as estimated by histopathology or the efficiency of tumor formation (tumor-forming dose 50% endpoint range = 10(2.8) to 10(7.5)); however, tumor invasion of the paravertebral muscles likely contributed to the scoliosis noted. In contrast to the effect of MDCK cells, tumor formation observed in newborn mice inoculated with highly tumorigenic, human-tumor-derived cell lines was not associated with FTT development. We suggest that tumor formation and FTT are characteristics of these MDCK cell inocula and that FTT represents a new syndrome that may be similar to the cachexia that develops in humans with cancer or other diseases.

Entities:  

Mesh:

Year:  2013        PMID: 24209967      PMCID: PMC3750667     

Source DB:  PubMed          Journal:  Comp Med        ISSN: 1532-0820            Impact factor:   0.982


  39 in total

1.  Evaluating virus-transformed cell tumorigenicity.

Authors:  A M Lewis; D W Alling; S M Banks; S Soddu; J L Cook
Journal:  J Virol Methods       Date:  1999-04       Impact factor: 2.014

2.  Central infusion of the melanocortin receptor antagonist agouti-related peptide (AgRP(83-132)) prevents cachexia-related symptoms induced by radiation and colon-26 tumors in mice.

Authors:  M A Joppa; K R Gogas; A C Foster; S Markison
Journal:  Peptides       Date:  2007-01-03       Impact factor: 3.750

Review 3.  Trivalent MDCK cell culture-derived influenza vaccine Optaflu (Novartis Vaccines).

Authors:  Alexander Doroshenko; Scott A Halperin
Journal:  Expert Rev Vaccines       Date:  2009-06       Impact factor: 5.217

4.  Heterogeneity of the tumorigenic phenotype expressed by Madin-Darby canine kidney cells.

Authors:  Romelda L Omeir; Belete Teferedegne; Gideon S Foseh; Joel J Beren; Philip J Snoy; Lauren R Brinster; James L Cook; Keith Peden; Andrew M Lewis
Journal:  Comp Med       Date:  2011-06       Impact factor: 0.982

5.  A cell line derived from normal dog kidney (MDCK) exhibiting qualities of papillary adenocarcinoma and of renal tubular epithelium.

Authors:  J Leighton; L W Estes; S Mansukhani; Z Brada
Journal:  Cancer       Date:  1970-11       Impact factor: 6.860

6.  Identification of two strains of MDCK cells which resemble separate nephron tubule segments.

Authors:  J C Richardson; V Scalera; N L Simmons
Journal:  Biochim Biophys Acta       Date:  1981-02-18

Review 7.  Continuous cell lines as a production system for influenza vaccines.

Authors:  Yvonne Genzel; Udo Reichl
Journal:  Expert Rev Vaccines       Date:  2009-12       Impact factor: 5.217

8.  Identification of 2-[2-[2-(5-bromo-2- methoxyphenyl)-ethyl]-3-fluorophenyl]-4,5-dihydro-1H-imidazole (ML00253764), a small molecule melanocortin 4 receptor antagonist that effectively reduces tumor-induced weight loss in a mouse model.

Authors:  Tricia J Vos; Andrei Caracoti; Jennifer L Che; Mingshi Dai; Cheryl A Farrer; Nancy E Forsyth; Stacey V Drabic; Robert A Horlick; Diana Lamppu; David L Yowe; Suresh Balani; Ping Li; Hang Zeng; Ingrid B J K Joseph; Luis E Rodriguez; Martin P Maguire; Michael A Patane; Christopher F Claiborne
Journal:  J Med Chem       Date:  2004-03-25       Impact factor: 7.446

9.  Assessing the tumorigenic phenotype of VERO cells in adult and newborn nude mice.

Authors:  Manu Manohar; Brian Orrison; Keith Peden; Andrew M Lewis
Journal:  Biologicals       Date:  2007-10-22       Impact factor: 1.856

10.  Suppression of tumorigenicity in an aggressive cervical carcinoma induced by protein zero, a nervous system IgCAM.

Authors:  L B Spiryda; D R Colman
Journal:  J Cell Sci       Date:  1998-11       Impact factor: 5.285

View more
  1 in total

1.  A novel canine kidney cell line model for the evaluation of neoplastic development: karyotype evolution associated with spontaneous immortalization and tumorigenicity.

Authors:  R Omeir; R Thomas; B Teferedegne; C Williams; G Foseh; J Macauley; L Brinster; J Beren; K Peden; M Breen; A M Lewis
Journal:  Chromosome Res       Date:  2015-05-10       Impact factor: 5.239

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.